Horacio Emanuel Jerez
Overview
Explore the profile of Horacio Emanuel Jerez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stabile S, Perez N, Jerez H, Simioni Y, Butassi E, Mizrahi M, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39796246
The properties of two hybrid nanoarchaeosomes (hybrid nanoARCs) made of archaeolipids extracted from the halophilic archaea and combining the properties of archaeolipid bilayers with metallic nanoparticles are explored here. BS-nanoARC,...
2.
Jerez H, Simioni Y, Ghosal K, Morilla M, Romero E
Beilstein J Nanotechnol
. 2024 May;
15:517-534.
PMID: 38774586
Sodium alendronate (ALN) is a very hydrosoluble and poorly permeable molecule used as an antiresorptive agent and with vascular anticalcifying capacity. Loaded into targeted nanovesicles, its anti-inflammatory activity may be...
3.
Jerez H, Altube M, Gandola Y, Gonzalez L, Gonzalez M, Morilla M, et al.
Eur J Pharm Biopharm
. 2021 Jan;
160:42-54.
PMID: 33440242
Nanoarchaeosomes are non-hydrolysable nanovesicles made of archaeolipids, naturally functionalised with ligand for scavenger receptor class 1. We hypothesized that nitrogenate bisphosphonate alendronate (ALN) loaded nanoarchaeosomes (nanoarchaeosomes(ALN)) may constitute more efficient...
4.
Higa L, Schilrreff P, Briski A, Jerez H, de Farias M, Portugal R, et al.
Colloids Surf B Biointerfaces
. 2020 Mar;
191:110961.
PMID: 32208325
Oral administration of antioxidant and anti-inflammatory drugs have the potential to improve the current therapy of inflammatory bowel disease. Success of oral treatments, however, depends on the capacity of drugs...
5.
Schilrreff P, Simioni Y, Jerez H, Caimi A, de Farias M, Portugal R, et al.
Colloids Surf B Biointerfaces
. 2019 Apr;
179:479-487.
PMID: 31005743
Oxidative stress plays an essential role in the pathogenesis and progression of inflammatory bowel disease. Co-administration of antioxidants and anti-inflammatory drugs has shown clinical benefits. Due to its significant reactive...
6.
Higa L, Jerez H, de Farias M, Portugal R, Romero E, Morilla M
Nanomedicine (Lond)
. 2017 Apr;
12(10):1165-1175.
PMID: 28447893
Aim: Develop nanoparticulate agents for oral targeted delivery of dexamethasone (Dex) to macrophages of inflamed mucosa. Materials & Methods: Solid archaeolipid nanoparticles (SAN-Dex) (compritol/Halorubrum tebenquichense polar archaeolipids/soybean phosphatidylcholine/Tween-80 4; 0.9;...